3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
10
Carcinoma, Non-Small-Cell Lung
5
Neoplasms
3
Glioblastoma
3
Colorectal Neoplasms
3
Skin Neoplasms
2
Ovarian Neoplasms
2
Myelodysplastic Syndromes
2
Lymphoma, Non-Hodgkin
2
Lung Neoplasms
2
Leukemia, Myeloid, Acute
2
Hot Flashes
2
Vulvodynia
1
Thromboembolism
1
Severe Acute Respiratory Syndrome
1
Recurrence
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Postoperative Hemorrhage
1
Pleural Effusion, Malignant
1
Platinum Resistant Ovarian Cancer
1
Parathyroid Neoplasms
1
Pancreatic Neoplasms
1
Pain, Postoperative
1
Neutropenia
1
Neoplasm, Residual
1
Neoplasm Metastasis
1
Myasthenia Gravis
1
Multiple Myeloma
1
Multiple Endocrine Neoplasia Type 1
1
Interventions
Rituximab
134
Cyclophosphamide
100
Vincristine
53
fludarabine phosphate
50
Prednisone
50
Doxorubicin
49
Etoposide
47
Peripheral Blood Stem Cell Transplantation
38
Mycophenolic Acid
37
Whole-Body Irradiation
35
Tacrolimus
29
Busulfan
27
Lenalidomide
26
Filgrastim
26
Cyclosporine
26
Melphalan
24
Methotrexate
21
Antilymphocyte Serum
21
Gemcitabine
18
ibritumomab tiuxetan
17
Granulocyte Colony-Stimulating Factor
17
Cytarabine
17
Carmustine
16
Radiotherapy
15
fludarabine
14
Carboplatin
14
Bendamustine Hydrochloride
14
pembrolizumab
13
ibrutinib
12
Sirolimus
11
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Lymphoma, Large B-Cell, Diffuse
×
Sodium Chloride
×
Clear all
No trials found.